Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI chatbot aims to ease postpartum loneliness and boost pelvic floor health

NCT ID NCT07223736

Not yet recruiting Symptom relief Sponsor: University of California, San Diego Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a generative AI chatbot can help new mothers learn about pelvic floor health and reduce feelings of loneliness after childbirth. Researchers will compare standard postpartum care with or without access to the chatbot over 4 weeks. The trial involves 130 first-time mothers who are 2-6 weeks postpartum.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
generative AI chatbot
What this could lead to
If it works, this could offer new mothers a simple, accessible way to get reliable postpartum health information and feel less isolated.
What could go wrong
This is a small, early-stage trial with only 130 participants. The chatbot may not improve knowledge or loneliness more than standard care, and results may not apply to all mothers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE (AI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder Pelvic Floor Disorders Psychological Well-Being puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTIFICIAL INTELLIGENCE (AI) CHATBOT DEPRESSION LONELINESS MENTAL HEALTH PELVIC FLOOR DISORDER PERITRAUMATIC DISTRESS POSTPARTUM WOMEN

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California San Diego

    La Jolla, California, 92093, United States

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.